Price target
264.210.00 0.00%
The 30 analysts offering 1 year price forecasts for 1BIIB have a max estimate of — and a min estimate of —.
Analyst rating
Based on 37 analysts giving stock ratings to 1BIIB in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
1BIIB EPS for the last quarter is 3.40 EUR despite the estimation of 3.22 EUR. In the next quarter EPS is expected to reach 3.66 EUR. Track more of BIOGEN financials and stay on top of what is up with the company.
In the next quarter BIOGEN revenue is expected to reach 2.19 B EUR. Check out BIOGEN revenue and earnings and make informed decisions.
According to analysts, 1BIIB price target is 264.21 EUR with a max estimate of 325.61 EUR and a min estimate of 186.06 EUR. Check if this forecast comes true in a year, meanwhile watch BIOGEN stock price chart and keep track of the current situation with 1BIIB news and stock market news.
We've gathered opinions of 37 analysts rating 1BIIB stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.